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Biopharmaceutical manufacturing using Chinese hamster ovary (CHO) cells requires the 
generation of high-producing clonal cell lines. During cell line development, cell cloning using 
fluorescence activated cell sorting (FACS) has the potential to combine isolation of single cells 
with sorting based on specific cellular attributes that correlate with productivity and/or growth, 
identifying cell lines with desirable phenotypes for manufacturing. This study describes the 
application of imaging flow cytometry (IFC) to characterize recombinant cell lines at the single 
cell level to identify cell attributes predictive of productivity. IFC assays to quantify organelle 
content, and recombinant heavy (HC) and light (LC) chain polypeptide and mRNA amounts in 
single cells were developed. The assays were then validated against orthogonal standard flow 
cytometry, western blot and qRT-PCR methods. We describe how these IFC assays may be 
used in cell line development and show how cellular properties can be correlated with 
productivity at the single cell level, allowing the isolation of such cells during the cloning 
process. Our analysis found HC polypeptide and mRNA to be predictive of productivity early 




Mammalian cells are the expression system of choice for the manufacture of therapeutic 
glycoproteins, such as monoclonal antibodies (mAbs), with over 70% being produced using 
CHO cells [1]. During cell line development, random integration of the expression plasmid and 
host cell heterogeneity results in varied expression levels, requiring extensive screening to 
identify highly productive clones [2-4]. Strategies to identify cells with increased probability 
of a high final titre at the cloning step could reduce timelines and diminish the total number of 
cell lines required to be screened at later stages to isolate such clones. FACS is commonly used 
for cell cloning in cell line development, having the advantage of being a high-throughput 
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method that can deposit single cells into wells of multi-well plates, supporting the regulatory 
demands for clonality, and assess cellular characteristics at the single-cell level. Combining 
FACS with post-sorting visualisation by fluorescent imaging showed that >99.5% of cells were 
clonal [5, 6].  Various flow cytometry-based screening methods have been developed to enable 
selective isolation of high producing clones. These include the capture of secreted mAb via 
binding to the cell surface using microbead technology , surface affinity matrix , introducing 
fluorescent markers into the vector  and vector modifications to enable secreted mAb to bind 
to cell surface proteins [10, 11]. Although such approaches give enrichment of high producing 
clones, they tend be labour intensive and time consuming.   
Recent advances in flow cytometry have been made with the development of a novel 
imaging flow cytometer, ImageStream (IS, Amnis/Merck). A key feature of the IS is that it 
combines the workflow and high throughput of conventional flow cytometers with the 
acquisition of up to 12 images per cell, enabling the spatial resolution and determination of 
quantitative morphology that can be achieved with microscopy [12]. IFC images that may be 
obtained include side-scatter, brightfield and up to nine fluorescent images, and such data has 
been used in a range of studies including assessing nuclear translocation [13], detection and 
discrimination of tumour cells and FISH studies [12]. The current study describes a novel 
approach to study recombinant CHO cell lines using IFC technology to identify cellular 
characteristics that correlate with productivity at the single cell level.  
 
2. Materials and Methods 
2.1 Cell culture  
CHO cell lines stably expressing a recombinant IgG1 kappa were grown in proprietary medium 
supplemented with 50 µM methionine sulfoximine (Sigma-Aldrich) and routinely sub cultured 




2.2 mAb quantitation 
IgG content in clarified culture medium was quantified by protein-A HPLC affinity 
chromatography on an Agilent HP1100 instrument (Agilent Technologies).  
2.3 IC HC and LC quantification by western blot 
Intracellular polypeptide was assessed using standard western analysis [14]. Membranes were 
incubated overnight with anti-IgG (FC) antibody conjugated to HRP or anti-kappa conjugated 
to HRP diluted at 1:10,000 (both from The Binding site). Rabbit anti-GAPDH antibody (Cell 
Signalling Technology) with a secondary anti-rabbit antibody conjugated to HRP (Jackson 
ImmunoResearch) was used to detect GAPDH. Blots were developed by incubation with ECL 
reagent (GE Healthcare Life Sciences) which was also used to measure band intensity for semi-
quantitation of proteins.  
2.4 HC and LC mRNA qPCR 
Total RNA was extracted using an RNeasy kit and treated with DNase (Qiagen). qRT-PCR 
was performed as previously reported [14].  
2.5 Flow cytometry assays 
For HC and LC protein, cells (1 x 106) were fixed using a 1:1 solution of Fixation Medium A 
(Invitrogen) and flow cytometry buffer (PBS with 5% BSA) for 15 min at RT and then 
incubated with Permeabilisation Medium B (Invitrogen) containing 1:20 goat f(ab’)2 anti-
human IgG Alexa Fluor conjugated to 488 (Invitrogen, excitation/emission: ~500/520 nm) and 
goat f(ab’)2 anti-human kappa conjugated to APC (Biolegend, excitation/emission: ~650/675 
nm)  for 15 min, before being washed and analysed. HC and LC mRNA were investigated 
using a PrimeFlow RNA kit with custom probes (Affymetrix, Merck) following the 
manufacturer protocol. Quantitation of organelles was performed by staining with Golgi-ID 
Green (excitation/emission: ~450/530 nm), ER-ID red (excitation/emission: ~580/660 nm), 
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Mito-ID red (excitation/emission: ~558/690 nm; all from Enzo Life Sciences) and MitoTracker 
Deep Red (Invitrogen, excitation/emisssion: ~644/665 nm) using the manufacturers’ protocols. 
DAPI (excitation/emisssion: ~340/450 nm) or Sytox nuclear (excitation/emission: ~444/480) 
counter-stain were used for nuclear localization.  
2.6 Flow cytometry 
Flow cytometry was performed on a BD Canto flow cytometer with the BD FACSDiva™ 
software. Cells were stained with DAPI and MitoTracker and excited with a violet (405 nm) 
and red (633 nm) laser and 10,000 events acquired for each sample. Doublets and debris were 
removed by gating on forward and side scatter dot plots. FlowJo software was used for 
statistical analysis. 
2.7 IFC  
An ImageStream® imaging flow cytometer (Merck) with INSPIRE® software was used to 
collect 10,000 events (or 10 min acquisition time). Images of each event were captured using 
a 60X objective with 405, 488 and 658 nm lasers, collecting fluorescent images in channels 7, 
2 and 5 respectively, alongside channel 1 and 9 for brightfield and channel 6 for darkfield. Cell 
classifier was set to 50 on area-lower limit on the brightfield channel to avoid debris 
acquisition. Analysis was performed using IDEAS® software (v6.2). Compensation settings 
were calculated using the built-in software algorithm in best-fit mode, and refined manually. 
Focused cells were gated using the plot of contrast versus gradient RMS features and single 
cells were gated using a dot plot of the aspect ratio versus cell area for the brightfield channel.  
 
3. Results and Discussion 
The first step in this study was to develop IFC assays to investigate the content of intracellular 
(IC) HC and LC polypeptide, HC and LC mRNA, and specific cellular organelles (Fig. 1A). 
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Key features of the IFC software are functions that enable spot counting (Fig. 1B) to quantify 
punctate staining, such as the Golgi, and masking to determine cell or organelle size by creating 
a mask on the brightfield image (Fig. 1C). Additionally, co-localization between two signals 
can also be determined (Fig. 1D).  
Standard flow cytometry is widely accepted as a robust method for investigating 
cellular attributes, however IFC is a relatively new technology and has not been as extensively 
used. We therefore assessed the reproducibility and consistency of results between standard 
flow cytometry and IFC. To do this, three separate vials of a recombinant CHO cell line were 
thawed and independently cultured in shake flasks. After the first passage, triplicate samples 
were taken from each flask on three separate days and stained with MitoTracker and DAPI 
(Fig. 2A). The percentage of double positive cells across instruments and days, ranged from 
94.8% to 100% (Fig. 2B-C). Intensity of nuclear and mitochondrial staining was consistent 
across instruments (Fig. 2D-G), with a good correlation between the signal intensity recorded 
by the different instruments for both dyes (Fig. 2 H, I; R2= 0.42 DAPI and 0.97 MitoTracker), 
giving confidence that observations by IFC could be transferred to standard flow cytometry. 
To investigate cellular differences between high/low producing cell lines, and 
correlations between organelle content and cell culture parameters, a panel of 19 cell lines 
expressing a model IgG1 mAb with a range of titres, specific productivities and growth in fed-
batch culture was used (Supplementary Table 1). IC HC and LC polypeptide and mRNA 
expression varied across the cell lines but also within individual cell lines at different 
timepoints of fed-batch culture (Fig. 3 and Supplementary Table 2). The amounts of HC 
polypeptide and mRNA on day 4, as determined by western blotting and qPCR respectively, 
were both predictive of final titre (Fig. 3A-B), as well as overall qP (data not shown), HC 
polypeptide and qP, Pearson’s correlation coefficient R = 0.77, and for HC mRNA, R = 0.82). 
No correlation was found between titre and LC content (data not shown) or between HC 
 7 
 
polypeptide and titre later in the culture (days 7 and 9). From these results, IC HC polypeptide 
and mRNA on day 4 could be used as markers of cellular productivity.  
IC HC and LC polypeptide and mRNA content was then assessed using IFC. HC 
polypeptide and mRNA content on day 3 showed a strong correlation with final titre (Fig. 3C, 
D), but at later time points (days 6 and 10), no such correlation was found. This suggests that 
IC HC polypeptide and mRNA content are predictive of final titre early in fed-batch culture, 
however, this predictive power is lost as the culture progresses as other factors begin to play a 
role in determining final titre, e.g. availability of translation machinery, folding/secretion and 
energy status of cell. LC polypeptide amounts showed no correlation with final titer or qP, 
although LC mRNA showed a positive correlation with final titer (R = 0.73 on day 3). Overall, 
these results are consistent with previous reports that IC HC polypeptide and mRNA content 
show a stronger correlation with mAb productivity than LC content, indicating that HC can be 
a limiting factor of final titre [15-20]. Although the correlation with LC was lower, there was 
some correlation between LC transcript and final titre, this not being unexpected as LC 
polypeptide is necessary to drive HC constant domain 1 (CH1) folding, mAb assembly and 
secretion [21, 22]. The reported differences as to whether HC or LC are limiting may reflect 
molecule-dependent and host cell-dependent differences. We note that the cell line with the 
highest HC mRNA content on day 3 did not have the highest titre. This cell line also had a high 
amount of LC mRNA on day 6, suggesting that above a certain transcript threshold, there might 
be potential bottlenecks further down the translation and secretion pathways [14, 16, 23]. 
Next, we investigated multiplexing HC mRNA and HC polypeptide assays at the single 
cell level and this revealed a positive correlation with titre, similar to that seen at the population 
level with qRT-PCR and western blotting assays (Fig 3E). IFC images revealed differential 
cytoplasmic localisation of the HC polypeptide and HC mRNA, consistent with previous 
findings of HC polypeptide residing in the ER and Golgi [24], and mRNA localised with 
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ribosomes on the ER surface (Fig. 3F). As both HC mRNA and polypeptide show a positive 
correlation with final titre early in culture and with each other, HC polypeptide was selected as 
the marker of productivity at the single cell level as the assay is more time and cost efficient 
than that for mRNA. HC polypeptide was then multiplexed with assays for different organelles.  
Differences in productivity between cell lines can be explained by a diverse range of 
mRNA levels, but also by differences in cellular properties that govern the growth and 
biosynthetic capacities of individual clones. Energy metabolism [25] and the protein synthesis 
[16], folding  and secretion  pathways can influence the final production and secretion of mAb. 
We therefore investigated with IS whether productivity differences observed between cell lines 
was correlated with variations in the mitochondria, ER and Golgi content of cells, as well as 
HC and LC polypeptide and mRNA. Correlations were investigated at the population 
(population median intensity vs. final titre for all cell lines) and single cell (intensity organelle 
vs. intensity HC) level (Supplementary Table 2). No linear correlations were found for 
individual cell lines between the mitochondrial content and HC polypeptide or mRNA amounts 
at the single cell level on any sampled days. Moreover, no relationships were found at the 
population level between mitochondrial content and productivity, or specific productivity on 
any of the days investigated. Mitochondrial content itself is not always reflective of cellular 
metabolism, as significant changes in the mitochondrial membrane potential (MMP) can occur 
without fluctuations in mitochondria numbers [28-30]. Studies have linked either high [29] or 
low [28] MMP with increased final titre, however we only considered mitochondrial biomass 
in this study. 
Additionally, no correlations were observed between HC content and ER content at the 
single cell level or at the population level between the ER or Golgi content and titre or specific 
productivity (Supplementary Table 2). Other studies report similar findings during the growth 
phase [1, 15] whilst our results show neither the ER content nor the Golgi content correlate 
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with productivity during the growth phase or at later stages of batch culture. We note reports 
that host cells with higher ER content prior to transfection result in the isolation of recombinant 
cells with higher titre [31].  
IFC currently has limitations in its application to sorting and isolation of cells in a cell 
line construction process. Currently IFC does not offer a high spatial resolution compared to 
traditional microscopes, which also allow for time-lapse experiments, and spatial-temporal 
analysis of the sample [32]. A further limitation of IFC is its maximum speed of 300 events/sec, 
which can only be reached with a high sample concentration of 108 cells/mL. This is quite 
different to the high-throughput of standard flow cytometry. The slow acquisition is mostly the 
result of limitations in focusing of cells, as out of focus cells are excluded from analysis [32]. 
Finally, there are currently no commercially available IFCs that have the ability to sort cells 
based on image-features, although that may change in the near future following the recent work 
by Nitta et al. on intelligent image-activated cell sorting [33]. 
Whilst the limitations are evident, the powerful IFC approach described here has the 
potential to identify novel cellular attributes that could be implemented to select for high 
producing cells (and eventually cells that have optimal growth profiles and specific product 
quality profiles) during the cell line development process. Single cell analysis by IFC could be 
combined with other approaches such as O-propargyl-puromycin labelling to investigate 
correlations between organelle content, HC and LC transcript and polypeptide and total protein 
synthesis rate [34]. As new live cell assays become available, further characterization of other 
cell characteristics can be investigated and correlated with desirable cell culture attributes such 
as productivity, growth or product quality.  
In this study of a panel of 19 cell lines, no differences in organelle content were 
observed between high and low producers of a model mAb that is considered easy-to-express. 
However, it is possible that cellular organelle amounts might differentiate between productivity 
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capability of cell lines making more difficult-to-express molecules. Moreover, the IFC tools 
described here could be applied to characterization of host cell populations and to identify 
potential targets for host cell engineering. Consistent with previous reports, we show that HC 
protein and mRNA are markers of productivity early in culture: this highlights a need for the 
development of new flow cytometric methods that allow the measurement of HC polypeptide 
or mRNA amounts in live cells, which could be used to enrich the proportion of high producers 
and improve the efficiency of cell line development.  
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Fig. 1. Sample images of the assays developed on the ImageStream. (A) Assays were developed 
in fixed cells for multiplexing with HC protein detection. The assays include ER, LC and HC 
mRNA, LC and HC polypeptide, and mitochondria. The Golgi assay was developed in live 
cells. Images show brightfield, fluorescent staining and an overlay of the staining. (B) Sample 
images featuring spot counting of the Golgi apparatus, with brightfield and fluorescent channel 
images with the number of spots on the right corner of the image. (C) Masking of the cell size 
based on the brightfield image, and of organelle size based on the threshold of the ER intensity. 
(D) Co-localization of HC mRNA and nucleus, which shows no co-localization, and HC and 








Fig. 2. (A) Sample ImageStream images showing the brightfield, nuclear staining (DAPI), 
mitochondria staining (MitoTracker) and composite image. (B & C) Average percentage of 
cells positive for both nuclear and mitochondrial staining for each vial on different days on 
ImageStream (B) and flow cytometry (C). (D-G) Average of DAPI median intensity (D, E) and 
MitoTracker median intensity (F, G) of individual shake flasks on day 3, representative of 
observations on other days, for ImageStream (D, F) and flow cytometry (E, G). The intensity 
of the nuclear staining was consistent between instruments and between shake flasks 
originating from the same vial, showing no statistical difference (Fig. 2D-E). For the 
mitochondrial staining, differences in intensity were present between shake flasks originating 
from the same vial and between vials, which could be due to intrinsic differences between 
cultures (Fig. 2F-G). Cultures were prepared and analysed in a different order to avoid order 
bias. Overall, there was a strong correlation between the signal measured by both instruments 
(Pearson’s correlation coefficient R = 0.65 for nuclear stain and R = 0.98 for mitochondrial 
stain). (H & I) DAPI median intensity of individual samples from day 3 (H) and MitoTracker 
(I) from flow cytometer versus ImageStream, with the R-squared values (coefficient of 





Fig. 3. (A, C) Correlation between titre and IC HC protein measured by western blotting (A) 
and IFC (C) (R2 = 0.84 where R2 is the coefficient of determination.). (B, D) Correlation 
between titre and HC mRNA measured by qRT-PCR (B) and IFC (D) (R = 0.79). (E, F) 
Multiplexing of HC mRNA and polypeptide with IFC (R = 0.65 for E)   
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Supplementary Table 1: Productivity and growth values for the 19 characterized cell lines in 





(pg / cell / 
day) 
Titer  
(mg / L) 
IVC  
(*106 cells / ml) 
19 10.2 859 67 
5 9.9 1326 153 
3 6.4 1343 224 
1 4.9 1496 303 
4 28.8 2014 83 
2 10.7 2485 237 
18 28.8 2494 94 
10 14.9 2505 152 
8 8.6 2778 324 
16 20.7 2789 155 
11 22.0 3098 163 
17 31.0 3281 127 
14 11.3 3327 325 
13 18.8 3364 188 
15 12.3 3450 319 
9 34.1 3800 127 
6 24.2 4007 167 
12 27.8 5201 206 








Supplementary Table 2: Pearson’s correlation coefficient between the organelle content on 
different days and the cell culture growth and productivity values. The last column provides 
the range of the Pearson’s correlation coefficient on individual clones between HC and 
mitochondrial or ER content at the single cell level.  
 








   
 
d3 -0.22 -0.04 -0.32 -0.44 0.03 to 0.52 
d6 0.23 0.25 -0.69 -0.37 0.02 to 0.46 
d10 -0.03 0.09 -0.07 0.18 - 0.03 to 0.49 
ER content 
   
 
d3 0.16 0.36 -0.64 -0.38 -0.12 to 0.54 
d6 0.12 0.40 -0.43 -0.38 -0.9 to 0.51 
d10 -0.48 -0.4 0.36 0.72 -0.16 to 0.58 
Golgi content 
   
 
d6 -0.11 0.26 -0.48 -0.41  
d10 -0.49 -0.27 0.18 0.61  
HC mRNA 
   
 
d3 0.79 0.92 -0.44 -0.38  
d6 0.31 0.55 -0.51 -0.32  
LC mRNA 
   
 
d3 0.58 0.83 -0.62 -0.42  
d6 0.12 0.34 -0.35 -0.26  
HC protein 
   
 
d3 0.84 0.60 -0.41 0.11  
d6 0.02 -0.11 0.46 0.47  
d10 0.12 0.06 -0.13 0.19  
LC protein 
   
 
d3 0.61 0.44 -0.90 0.22  
d6 -0.02 -0.03 0.32 0.47  
d10 0.06 -0.03 -0.27 -0.10  
 
 
 
